econazole has been researched along with oxiconazole in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (54.55) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 2 (18.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A | 1 |
Bron, S; Chambon, M; Colau, D; Majjigapu, SR; Michielin, O; Pilotte, L; Röhrig, UF; Turcatti, G; Van den Eynde, BJ; Vogel, P; Zoete, V | 1 |
Frosch, PJ; Raulin, C | 1 |
Bastide, JM; Bastide, M; Jouvert, S; Lebecq, JC; Mallie, M; Montes, B | 1 |
Abbott, AB; Odds, FC; Webster, CE | 1 |
Gip, L | 1 |
Gouveia, DC; Jones da Silva, C | 1 |
Bauer, E; Stüttgen, G | 1 |
Orengo, I; Rosen, T; Schell, BJ | 1 |
Benko, I; Hernádi, F; Kiss, A; Kovács, P; Kraicsovits, F; Megyeri, A; Somogyi, G; Tegyey, Z | 1 |
3 trial(s) available for econazole and oxiconazole
Article | Year |
---|---|
Comparison of oxiconazole (Ro 13-8996) and econazole in dermatomycoses.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis, Cutaneous; Child; Clinical Trials as Topic; Dermatomycoses; Double-Blind Method; Econazole; Female; Humans; Imidazoles; Male; Middle Aged; Ointments; Tinea Versicolor | 1984 |
Oxiconazole in the treatment of vaginal candidiasis: single dose versus 3-day treatment with econazole.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Administration Schedule; Econazole; Female; Humans; Imidazoles; Middle Aged; Random Allocation | 1984 |
Anti-inflammatory activity of antifungal preparations.
Topics: Adult; Allylamine; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Chemoprevention; Ciclopirox; Double-Blind Method; Econazole; Erythema; Female; Humans; Hydrocortisone; Imidazoles; Ketoconazole; Male; Middle Aged; Naphthalenes; Pyridones; Terbinafine; Ultraviolet Rays | 1997 |
8 other study(ies) available for econazole and oxiconazole
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity | 2012 |
Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
Topics: Animals; Antifungal Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Molecular Dynamics Simulation; Molecular Structure; Structure-Activity Relationship | 2014 |
Contact allergy to imidazole antimycotics.
Topics: Adult; Aged; Antifungal Agents; Chemical Phenomena; Chemistry; Clotrimazole; Drug Eruptions; Econazole; Female; Humans; Imidazoles; Male; Miconazole; Middle Aged; Prospective Studies | 1988 |
[Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy].
Topics: Antifungal Agents; Candida albicans; Clotrimazole; Cytoplasm; Econazole; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Spheroplasts; Triazoles | 1988 |
Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
Topics: Antifungal Agents; Aspergillus; Candida; Clotrimazole; Econazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Morpholines; Triazoles | 1984 |
Bioavailability, skin- and nailpenetration of topically applied antimycotics.
Topics: Administration, Topical; Antifungal Agents; Biological Availability; Econazole; Humans; Imidazoles; Morpholines; Nails; Skin | 1982 |
Comparison of the toxicity of fluconazole and other azole antifungal drugs to murine and human granulocyte-macrophage progenitor cells in vitro.
Topics: Animals; Antifungal Agents; Azoles; Bone Marrow; Cells, Cultured; Clotrimazole; Dose-Response Relationship, Drug; Econazole; Female; Fluconazole; Granulocytes; Hematopoietic Stem Cells; Humans; Imidazoles; Inhibitory Concentration 50; Ketoconazole; Macrophages; Male; Mice; Miconazole; Species Specificity; Stem Cells | 1999 |